Novo Holdings Harmony Biosciences Holdings, Inc. Transaction History

Novo Holdings

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$34.09 - $43.91 $1.36 Million - $1.76 Million	-40,000 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$25.68 - $38.61 $35.5 Million - $53.4 Million	-1,382,953 Reduced 97.19%	40,000 $1.53 Million
Q2 2021 Aug 16, 2021	SELL	$25.96 - $33.44 $49.7 Million - $64 Million	-1,913,425 Reduced 57.35%	1,422,953 $40.2 Million
Q1 2021 May 17, 2021	SELL	$27.56 - $40.37 $7.88 Million - $11.5 Million	-286,093 Reduced 7.9%	3,336,378 $110 Million
Q4 2020 Feb 16, 2021	SELL	$31.74 - $51.34 $4.21 Million - $6.8 Million	-132,502 Reduced 3.53%	3,622,471 $131 Million
Q3 2020 Nov 16, 2020	BUY	$30.96 - $44.39 $116 Million - $167 Million	3,754,973 New	3,754,973 $127 Million

242

45.1M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Novo Holdings, based on Form 13F filings with the SEC.

Stay updated on Novo Holdings with notifications on news.